AFP and hepatocellular carcinoma: Studies conducted in Egypt, the country known to have the highest prevalence of hepatitis C, showed that the prevalence of an increase in AFP levels above 10 ng/ml in HCC patients with etiology of hepatitis C was proven to be less frequent, occurring only in 11.6% patients [31].